MS4A1 and lymphoma: Immunophenotypically, MCL lymphoma cells are positive for pan-B cell markers such as CD19 and CD20 and are usually CD5+, SOX11+, FMC7+, CD10−, and CD23− though variations in some subsets of patients have been reported.